Cao, Y. et al. 2026. Diagnostic Value of Serum Fibroblast Growth Factor 21 Combined with Fibrosis-4 Index for Hepatic Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease. Turkish Journal of Gastroenterology. 37, 7 (Jun. 2026), 782–792. DOI:https://doi.org/10.5152/tjg.2026.25740.